Hospital do Rim e Hipertensão
11
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
55%
6 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
Role: collaborator
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Role: lead
Evaluation of APOL1 Gene Variants in Kidney Donors and Their Impact on Long-term Renal Function in Donors and Recipients
Role: lead
Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil
Role: lead
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
Role: lead
Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients
Role: lead
Dental Extractions Among Renal Transplant Recipients
Role: collaborator
Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Role: lead
Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors
Role: lead
Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations
Role: lead
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
Role: lead
All 11 trials loaded